SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-012025
Filing Date
2021-02-26
Accepted
2021-02-26 14:16:23
Documents
13
Period of Report
2021-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea136641-8k_augmedix.htm   iXBRL 8-K 27638
2 LOCK-UP AGREEMENT, DATED FEBRUARY 22, 2021, BY AND BETWEEN AUGMEDIX, INC. ea136641ex10-1_augmedix.htm EX-10.1 127872
  Complete submission text file 0001213900-21-012025.txt   341067

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE augx-20210222.xsd EX-101.SCH 3177
4 XBRL LABEL FILE augx-20210222_lab.xml EX-101.LAB 35264
5 XBRL PRESENTATION FILE augx-20210222_pre.xml EX-101.PRE 23137
6 EXTRACTED XBRL INSTANCE DOCUMENT ea136641-8k_augmedix_htm.xml XML 3547
Mailing Address 1161 MISSION STREET SUITE LL SAN FRANCISC CA 94103
Business Address 1161 MISSION STREET SUITE LL SAN FRANCISC CA 94103 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

IRS No.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56036 | Film No.: 21687292
SIC: 7389 Services-Business Services, NEC